课题基金 / 基金详情

项目摘要

项目成果

LARRY ARTHUR的其他基金

相关文献

中文摘要
翻译
该合同资金支持由国家癌症研究所(NCI)生物储存库和生物标本研究办公室管理的生物标本研究网络。2006年初,NCI生物储存库和生物标本研究办公室(OBBR)启动了生物标本研究网络(BRN),以系统地解决个体标本类型中特定变量对给定分析平台分子数据的影响。BRN的目标是通过赞助、指导和合作研究来解决这些问题,以评估用于临床诊断和癌症研究目的的人类标本预分析变量对基因组和蛋白质组学研究结果的影响。通过与科学界交流这类研究的结果,BRN旨在显著提高nci资助的基于生物标本的研究的质量。BRN的研究结果将支持NCI的发现工作,并在“NCI生物标本资源最佳实践”的基础上,为生物标本的收集、处理、储存和分析提供基于证据的最佳实践。
英文摘要
This contract funding supports the Biospecimen Research Network, managed by the National Cancer Institute (NCI) Office of Biorepositories and Biospecimen Research."In early 2006, the NCI Office of Biorepositories and Biospecimen Research (OBBR) initiated the Biospecimen Research Network (BRN) to systematically address the impact of specific variables in individual specimen types on molecular data from given analysis platforms. The goal of the BRN is to address these issues by sponsoring, conducting, and collaborating on studies to assess the effects of human specimen pre-analytical variables on the outcome of genomic and proteomic studies conducted for clinical diagnosis and cancer research purposes. By communicating the results of such research to the scientific community, the BRN aims to significantly improve the quality of NCI-funded biospecimen-based research. The results of BRN research will support NCI discovery efforts and contribute to the development of evidence-based best practices for the collection, processing, storage, and analysis of biospecimens, building on the ""NCI Best Practices for Biospecimen Resources."" Based on this vision, the BRN has been designed to address the following challenges: * Bridging the gap between existing clinical practice for biospecimens and emerging technologies for personalized diagnostics and therapies * Defining the most significant variables for prospective collection of tissues, blood, and bodily fluids * Developing evidence-based biospecimen quality indicators for specific analytical platforms The activities of the BRN program to date include the following: * A public outreach effort to define issues around human specimen research and identify the most pressing needs for human analyte standardization. Activities include an annual meeting, the BRN Symposium. * Provision of consultative services on biospecimen issues for programs within the NCI and NIH * A series of research projects underway at the BRN laboratory located at the Advanced Technology Center in Gaithersburg with intramural and extramural collaborators * Development of a searchable Web site of the existing biospecimen literature, the Biospecimen Research Database "
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DCTD Synthetic Chemistry
Laboratory of Molecular Technology
Pathology/Histotechnology
Comp IT Program for Facilitating Drug Discovery & Development